- P-ISSN 1225-0163
- E-ISSN 2288-8985
- Apply for Authority
- P-ISSN1225-0163
- E-ISSN2288-8985
- SCOPUS, ESCI, KCI
Article Detail
Home > Article Detail
Characteristics of tamiflu occurrence in surface water using LC/MS/MS
Analytical Science and Technology / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
2010, v.23 no.2, pp.147-154
https://doi.org/10.5806/AST.2010.23.2.147
&
(2010). Characteristics of tamiflu occurrence in surface water using LC/MS/MS. Analytical Science and Technology, 23(2), 147-154, https://doi.org/10.5806/AST.2010.23.2.147
- Downloaded
- Viewed
Abstract
Oseltamivir carboxylate (OC) and Oseltamivir ethylester (OE) were analyzed to evaluate the environmental distribution in pandemic season in Korea. The detected concentration of OE was the range of 0.008~0.087 μg/L, and OC was the range of 0.029~0.287 μg/L. The detected concentration of OC in this study was two times higher than reported concentration of OC in river water in Japan. But, these analytical results cannot be directly compared to the previous reported concentration, because of the different sampling period.
- keywords
- tamiflu, oseltamivir ethylester phosphate, oseltamivir ethylester, oseltamivir carboxylate, LC/MS/MS
Reference
1
1. 국립환경과학원, “환경 중 의약물질 분석방법 연구 및 노출실태조사(I)”, 2006.
2
2. 국립환경과학원, “환경 중 의약물질 분석방법 연구 및 노출실태조사(II)”, 2007.
3
3. 국립환경과학원, “잔류의약물질 분석방법 연구 및 실태조사(I)”, 2008.
4
4. 국립환경과학원, “잔류의약물질 분석방법 연구 및 실태조사(II)”, 2009.
5
5. S. D. Kim, J. Cho, I. S. Kim, B. J. Vanderford and S. A. Snyder, Water Res., 41, 1013-1021(2007).
6
6. K. Choi, Y. Kim, J. Park, C. K Park, M. Y. Kim, H. S. Kim and P. Kim, Sci. Total Environ., 405, 120-128(2008).
7
7. Y. Kim, J. Jung, M. Kim, J. Park, A. B. A. Boxall and K. Choi, Environ. Toxicol. Phar., 26, 167-176(2008).
8
8. D. Fatta, A. Nikolaou, A. Achilleos and S. Meriç, Trends iAnn alytical Chemistry, 26(6), 515-533(2007).
9
9. K. Kümmerer, J. Environ. Manage., 90, 2354-2366(2009).
10
10. N. Kemper, Ecological Indicators, 8, 1-13(2008).
11
11. E.U., http://www.poseidon.geo.uni-mainz.de/publications.htm
12
12. US EPA, Method 1694: “Pharmaceuticals and Personal Care Products in Water, Soil, Sediment and Biosolids by HPLC/MS/MS”, 2007.
13
13. U.S. EPA, http://www.epa.gov/ppcp/
14
14. M. Gros, M. Petrovi , A. Ginebreda and Damià Barceló, Environ. Int., 36, 15-26(2010).
15
15. N. Nakada, H. Shinohara, A. Murata, K. Kiri, S. Managaki, N. Sato and H. Takada, Water Res., 41, 4373- 4382(2007).
16
16. J. Fick, R. H. Lindberg, M. Tysklind, P. D. Haemig, J. Waldenström, A. Wallensten, and Björn Olsen, PLoS One, 2(10), e968(2007).
17
17. N. Vieno, T. Tuhkanen and L. Kronberg, Water Res., 41, 1001-1021(2007).
18
18. C. G. Daughton, “In Pharmaceuticals in the Environment”, 2nd Ed., 463-495, K. Küummerer, Ed., Springer, U.S.A., 2004.
19
19. EMEA, “Note for Guidance on Environmental Risk Assessment of Medicinal Products for Human Use.” CPMO/SWP/4447/00 draft corr. Available from <http://www.ema.europa.eu/pdfs/human/swp/444700en.pdf>, 2003.
20
20. U. S. FDA, Guidance for Industry: Environmental Assessment of Human Drug and Biologics Applications, 1998.
21
21. J. O. Straub, Ecotox. Environ. Safe., 72, 1625-1634(2009).
22
22. M. Carballa, F. Omil and J. Lema, Water Res., 39, 4790-4796(2005).
23
23. P. K. Jjemba, Ecotox. Environ. Safe., 63, 113-130(2006).
24
24. C. Prasse, M. Schlüsener, R. Schulz and T.A. Ternes, Environ Sci Technol., doi: 10.1021/es903216p [Accepted 11 January 2010]
25
25. B. I. Escher, N. Bramaz, J. Lienert, J. Neuwoehner and J. O. Straub, Aquatic Toxicology, 96, 194-202(2010).
26
26. H. Söderström, J. D. Järhult, B. Olsen, R. H. Lindberg, H. Tanaka and J. Fick, PLoS One, 4(6), e6064(2009).
27
27. G. C. Ghosh, N. Nakada, N. Yamashita and H. Tanaka, Environmental Health Perspectives, 118(1), 103- 107(2010).
28
28. U.S FDA, “Endocrine Disruptors and Pharmaceuticla Active Compounds in Drinking Water Workshop”, 2000.
29
29. A. C. Singer, M. A. Nunn, E. A. Gould and A. C. Johnson, Environmental Health Perspectives, 115(1), 102- 106(2007).
30
30. O. A. H. Jones, N. Voulvoulis and J. N. Lester, Bulletin of the World Health Organization, 81(10), 768-769(2003).
Other articles from this issue
- Single crystal growth of ZnWO4 by the Czochralski method and characterization
- Comparison of TVOCs emission characterization of paint and putty according to the amendment of test specimen preparation method
- Simultaneous analysis of β-lactam antibiotics in surface water
- Analytical method of New POPs in environmental samples
- Evaluation of TVOC regulation level of sealant products in accordance with simultaneous revision of testing method and regulation value in the law of indoor air quality management
- Characteristics of tamiflu occurrence in surface water using LC/MS/MS
- Determination of bromate in bottled mineral water in Korea
- Tritium concentration in rain with seasonal variation
- A glucose biosensor based on deposition of glucose oxidase onto Au nanoparticles poly(maleic anhydride)-grafted multiwalled carbon nanotube electrode
- Study on the immobilization of plant glutathione S-transferase for development of herbicide detection kit
- Determination of ibuprofen and its metabolites in human urine by GC-MS
- Analysis and risk assessment of polycyclic aromatic hydrocarbons (PAHs) in seafood from oil contaminated bay
- Determination of polycyclic aromatic hydrocarbons in processed foods
- A study on the measurement of hangul signature by SHWI
- A study on surface modification of Ag powder for developing latent fingerprints
- more
Recommanded Articles
This website recommended the use the Chrome browser for journal website.